FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

420736004: Conventional release eye suspension (dose form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2616717019 Eye suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2673151016 Ophthalmic suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3620934010 Conventional release eye suspension (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3620935011 Conventional release eye suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Eye suspension est un(e) (attribut) Suspension false Inferred relationship Some
Eye suspension est un(e) (attribut) forme pharmaceutique pour usage oculaire (forme pharmaceutique) true Inferred relationship Some
Eye suspension Has dose form administration method (attribute) Apply (administration method) true Inferred relationship Some
Eye suspension Has dose form intended site (attribute) Ocular (intended site) true Inferred relationship Some
Eye suspension Has dose form release characteristic (attribute) Conventional release (release characteristic) true Inferred relationship Some
Eye suspension Has basic dose form (attribute) Suspension true Inferred relationship Some
Eye suspension Has dose form transformation (attribute) No transformation true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) a une forme pharmaceutique (attribut) True Eye suspension Inferred relationship Some
Difluprednate 500 microgram/mL eye suspension a une forme pharmaceutique (attribut) True Eye suspension Inferred relationship Some
Product containing precisely fluorometholone acetate 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) a une forme pharmaceutique (attribut) True Eye suspension Inferred relationship Some
Levobetaxolol 5 mg/mL eye suspension a une forme pharmaceutique (attribut) True Eye suspension Inferred relationship Some
Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) a une forme pharmaceutique (attribut) False Eye suspension Inferred relationship Some
Product containing precisely ciclosporin 500 microgram/1 milliliter conventional release eye suspension (clinical drug) a une forme pharmaceutique (attribut) True Eye suspension Inferred relationship Some
collyre en suspension est un(e) (attribut) False Eye suspension Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension a une forme pharmaceutique (attribut) True Eye suspension Inferred relationship Some
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension (product) a une forme pharmaceutique (attribut) False Eye suspension Inferred relationship Some
Nepafenac 1 mg/mL eye suspension a une forme pharmaceutique (attribut) False Eye suspension Inferred relationship Some
Product containing precisely natamycin 50 milligram/1 milliliter conventional release eye suspension (clinical drug) a une forme pharmaceutique (attribut) True Eye suspension Inferred relationship Some
Levobetaxolol hydrochloride 0.5% ophthalmic suspension (product) a une forme pharmaceutique (attribut) False Eye suspension Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) a une forme pharmaceutique (attribut) True Eye suspension Inferred relationship Some
Prednisolone acetate 25mg/mL suspension (product) a une forme pharmaceutique (attribut) False Eye suspension Inferred relationship Some
Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) a une forme pharmaceutique (attribut) True Eye suspension Inferred relationship Some
Prednisolone acetate 1.25 mg/mL eye suspension a une forme pharmaceutique (attribut) True Eye suspension Inferred relationship Some
Prednisolone acetate 10 mg/mL eye suspension a une forme pharmaceutique (attribut) True Eye suspension Inferred relationship Some
Medrysone 10 mg/mL eye suspension a une forme pharmaceutique (attribut) True Eye suspension Inferred relationship Some
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye suspension (clinical drug) a une forme pharmaceutique (attribut) True Eye suspension Inferred relationship Some
Product containing precisely fluorometholone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) a une forme pharmaceutique (attribut) True Eye suspension Inferred relationship Some
Product containing precisely fluorometholone 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) a une forme pharmaceutique (attribut) True Eye suspension Inferred relationship Some
Loteprednol etabonate 5 mg/mL eye suspension a une forme pharmaceutique (attribut) True Eye suspension Inferred relationship Some
Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) a une forme pharmaceutique (attribut) True Eye suspension Inferred relationship Some
Tetracycline hydrochloride 1%wv suspension (product) a une forme pharmaceutique (attribut) False Eye suspension Inferred relationship Some
Dexamethasone 500 microgram/mL and tobramycin 3 mg/mL eye suspension a une forme pharmaceutique (attribut) True Eye suspension Inferred relationship Some
Besifloxacin 6 mg/mL eye suspension a une forme pharmaceutique (attribut) True Eye suspension Inferred relationship Some

This concept is not in any reference sets

Back to Start